Compare $FTH vs $STTK | Chartloom

Compare

$FTH vs $STTK

Faeth Therapeutics, Inc · Shattuck Labs Inc

FTH

Faeth Therapeutics, Inc

STTK

Shattuck Labs Inc

Compare $FTH vs $STTK

Comparing Faeth Therapeutics, Inc and Shattuck Labs Inc

FTHFaeth Therapeutics, Inc

STTKShattuck Labs Inc

FTHFaeth Therapeutics, Inc

Market cap

$671M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

79.1%

52W performance

79.1%

FCF yield

-5.0%

STTKShattuck Labs Inc

Market cap

$540M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.6%

YTD performance

60.9%

52W performance

149.8%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FTH

STTK

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

STTK

Shattuck Labs Inc

Market Cap

FTH$671M

STTK$540M

Enterprise Value

FTH$644M

STTK$476M

Price

FTH$26.03

STTK$5.97

P/E Ratio

FTHN/A

STTKN/A

P/S Ratio

FTH0.00x

STTK539.51x

EV/Sales

FTH0.00x

STTK476.21x

EV/EBITDA

FTH0.00x

STTK0.00x

P/B Ratio

FTH4.08x

STTK3.20x

P/FCF Ratio

FTHN/A

STTKN/A

EV/FCF

FTH-19.02x

STTK-11.55x

PEG Ratio

FTHN/A

STTKN/A

Forward P/E (NTM)

FTHN/A

STTKN/A

Forward P/S (NTM)

FTHN/A

STTKN/A

Revenue (TTM)

FTH$0

STTK$1M

Revenue Growth (YoY)

FTHN/A

STTK-66.6%

Forward Rev Growth

FTH77.6%

STTK118.7%

Gross Margin (TTM)

FTH0.0%

STTK0.0%

Operating Margin (TTM)

FTH0.0%

STTK0.0%

EBITDA Margin (TTM)

FTH0.0%

STTK-5212.2%

Net Margin (TTM)

FTH0.0%

STTK-5256.8%

FCF Margin (TTM)

FTHN/A

STTK-4124.0%

Net Income (TTM)

FTH$-196M

STTK$-53M

FCF (TTM)

FTH$-34M

STTK$-41M

EPS (TTM)

FTH-$34.65

STTK-$0.41

ROE (TTM)

FTH-18959.0%

STTK-4357.0%

ROA (TTM)

FTH-17568.0%

STTK-4090.0%

ROIC (TTM)

FTH-18946.0%

STTK-4357.0%

Cash

FTH$27M

STTK$63M

Debt

FTH$0

STTK$0

Net Cash/Debt

FTH$27M

STTK$63M

Current Ratio (TTM)

FTH19.69x

STTK27.59x

Quick Ratio (TTM)

FTH19.55x

STTK26.94x

Debt/Equity (TTM)

FTH0.00x

STTK0.00x

Debt/Assets (TTM)

FTH0.0%

STTK0.0%

Interest Coverage (TTM)

FTHN/A

STTKN/A

Net Debt/EBITDA (TTM)

FTH0.00x

STTK0.00x

Beta

FTH2.05

STTK0.98

52W Performance

FTH79.1%

STTK149.8%

YTD Performance

FTH79.1%

STTK60.9%

% from 52W High

FTH-38.2%

STTK-28.3%

% from 52W Low

FTH93.8%

STTK251.2%

Asset Turnover (TTM)

FTH0.00x

STTK0.01x

FCF Yield (TTM)

FTH-5.0%

STTK-7.6%

Earnings Yield (TTM)

FTH-29.1%

STTK-9.7%

Dividend Yield (TTM)

FTHN/A

STTKN/A

Rule of 40

FTH0.0

STTK-4,190.6

EV/GP/RG

FTHN/A

STTKN/A

Ticker research

View FTH research View STTK research

Metric	FTH Faeth Therapeutics, Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$671M	$540M
Enterprise Value	$644M	$476M
Price	$26.03	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	539.51x
EV/Sales	0.00x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.08x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.02x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	77.6%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5212.2%
Net Margin (TTM)	0.0%	-5256.8%
FCF Margin (TTM)	N/A	-4124.0%
Net Income (TTM)	$-196M	$-53M
FCF (TTM)	$-34M	$-41M
EPS (TTM)	-$34.65	-$0.41
ROE (TTM)	-18959.0%	-4357.0%
ROA (TTM)	-17568.0%	-4090.0%
ROIC (TTM)	-18946.0%	-4357.0%
Financial Health
Cash	$27M	$63M
Debt	$0	$0
Net Cash/Debt	$27M	$63M
Current Ratio (TTM)	19.69x	27.59x
Quick Ratio (TTM)	19.55x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	0.98
52W Performance	79.1%	149.8%
YTD Performance	79.1%	60.9%
% from 52W High	-38.2%	-28.3%
% from 52W Low	93.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-5.0%	-7.6%
Earnings Yield (TTM)	-29.1%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View FTH research	View STTK research

Valuation

P/S Ratio

FTH

0.00x

STTK

539.51x

EV/FCF

FTH

-19.02x

STTK

-11.55x

Growth & revenue

Revenue Growth TTM

STTK

-66.6%

Forward Revenue Growth

STTK

118.7%

FTH

77.6%

Profitability & performance

Gross Margin

FTH

0.0%

STTK

0.0%

ROE

STTK

-4357.0%

FTH

-18959.0%

FCF Yield %

FTH

-5.0%

STTK

-7.6%

52-Week Performance

STTK

149.8%

FTH

79.1%

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

STTK

Shattuck Labs Inc

Market Cap

FTH$671M

STTK$540M

Enterprise Value

FTH$644M

STTK$476M

Price

FTH$26.03

STTK$5.97

P/E Ratio

FTHN/A

STTKN/A

P/S Ratio

FTH0.00x

STTK539.51x

EV/Sales

FTH0.00x

STTK476.21x

EV/EBITDA

FTH0.00x

STTK0.00x

P/B Ratio

FTH4.08x

STTK3.20x

P/FCF Ratio

FTHN/A

STTKN/A

EV/FCF

FTH-19.02x

STTK-11.55x

PEG Ratio

FTHN/A

STTKN/A

Forward P/E (NTM)

FTHN/A

STTKN/A

Forward P/S (NTM)

FTHN/A

STTKN/A

Revenue (TTM)

FTH$0

STTK$1M

Revenue Growth (YoY)

FTHN/A

STTK-66.6%

Forward Rev Growth

FTH77.6%

STTK118.7%

Gross Margin (TTM)

FTH0.0%

STTK0.0%

Operating Margin (TTM)

FTH0.0%

STTK0.0%

EBITDA Margin (TTM)

FTH0.0%

STTK-5212.2%

Net Margin (TTM)

FTH0.0%

STTK-5256.8%

FCF Margin (TTM)

FTHN/A

STTK-4124.0%

Net Income (TTM)

FTH$-196M

STTK$-53M

FCF (TTM)

FTH$-34M

STTK$-41M

EPS (TTM)

FTH-$34.65

STTK-$0.41

ROE (TTM)

FTH-18959.0%

STTK-4357.0%

ROA (TTM)

FTH-17568.0%

STTK-4090.0%

ROIC (TTM)

FTH-18946.0%

STTK-4357.0%

Cash

FTH$27M

STTK$63M

Debt

FTH$0

STTK$0

Net Cash/Debt

FTH$27M

STTK$63M

Current Ratio (TTM)

FTH19.69x

STTK27.59x

Quick Ratio (TTM)

FTH19.55x

STTK26.94x

Debt/Equity (TTM)

FTH0.00x

STTK0.00x

Debt/Assets (TTM)

FTH0.0%

STTK0.0%

Interest Coverage (TTM)

FTHN/A

STTKN/A

Net Debt/EBITDA (TTM)

FTH0.00x

STTK0.00x

Beta

FTH2.05

STTK0.98

52W Performance

FTH79.1%

STTK149.8%

YTD Performance

FTH79.1%

STTK60.9%

% from 52W High

FTH-38.2%

STTK-28.3%

% from 52W Low

FTH93.8%

STTK251.2%

Asset Turnover (TTM)

FTH0.00x

STTK0.01x

FCF Yield (TTM)

FTH-5.0%

STTK-7.6%

Earnings Yield (TTM)

FTH-29.1%

STTK-9.7%

Dividend Yield (TTM)

FTHN/A

STTKN/A

Rule of 40

FTH0.0

STTK-4,190.6

EV/GP/RG

FTHN/A

STTKN/A

Ticker research

View FTH research View STTK research

Metric	FTH Faeth Therapeutics, Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$671M	$540M
Enterprise Value	$644M	$476M
Price	$26.03	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	539.51x
EV/Sales	0.00x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.08x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.02x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	77.6%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5212.2%
Net Margin (TTM)	0.0%	-5256.8%
FCF Margin (TTM)	N/A	-4124.0%
Net Income (TTM)	$-196M	$-53M
FCF (TTM)	$-34M	$-41M
EPS (TTM)	-$34.65	-$0.41
ROE (TTM)	-18959.0%	-4357.0%
ROA (TTM)	-17568.0%	-4090.0%
ROIC (TTM)	-18946.0%	-4357.0%
Financial Health
Cash	$27M	$63M
Debt	$0	$0
Net Cash/Debt	$27M	$63M
Current Ratio (TTM)	19.69x	27.59x
Quick Ratio (TTM)	19.55x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	0.98
52W Performance	79.1%	149.8%
YTD Performance	79.1%	60.9%
% from 52W High	-38.2%	-28.3%
% from 52W Low	93.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-5.0%	-7.6%
Earnings Yield (TTM)	-29.1%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View FTH research	View STTK research